Mannkind Corp is based out of Danbury. Focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The company has commenced Phase 3 clinical trials in Europe of its lead product, the Technosphere Insulin System, to study its potential for the treatment of diabetes.Whalewisdom has at least 222 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-07-15. The notice included securities offered of Debt,Other
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
MANNKIND CORP1 CASPER STREET
DANBURY CT 06810
Business Phone: 818-661-5000
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS